Court termeMoyen termeLong termeSignaux

Aclaris Therapeutics Inc [ACRS]

Bourse : NASDAQ
Secteur : Healthcare
Industrie : Biotechnology
Dernière mise à jour 22 Jun 2026 @ 10:08 (Exchange is open)
Dernier : $0 0.00%
-0.41 (↓)
GaG Algo Score™
v1.0
Court
-0.41 (↓)
Moyen
0.74 (↓)
Long
1.25 (↓)

Statistiques

Volume du jour 0
Volume moyen 0
Capitalisation 542.68M
BPA $-0.150 (Q1 | 2026-05-07)
Prochaine date de résultats ($-0.160) 2026-08-06
ATR14 $0.246 (5.47%)
Mouvement journalier possible $4.38 - $4.62 (5.62%)

Niveaux de support et résistance

Ligne

Données pivot

Statistiques pivot
Métrique Moyenne Médiane Écart type
Gain % 44.76% 47.84% 22.70%
Perte % -18.84% -15.87% 9.70%
Durée 20.9d 18d 14.5d
Total des pivots trouvés 13
Segments gain/perte 12 (6 Gain / 6 Perte)
Dernier pivot Top @ $4.71 le 2026-06-04
Variation depuis le dernier pivot $-0.21 (-4.46%)
Prévision du prochain pivot Dernier : $0.00
Prochain type prévu Bottom
Prix prévu (moy.) $3.82
Prix prévu (médiane) $3.96
Fourchette de prix prévue (~68%) $3.37 - $4.28
Variation vers cible moyenne $3.82 (N/A)
Date prévue (moy.) 2026-06-24
Plage de dates prévue (~68%) 2026-06-10 - 2026-07-09
Base Based on 6 historical losses (Avg: -18.84%, Median: -15.87%, StdDev of Abs: 9.70%) and duration (Avg: 20.9 days, StdDev: 14.5 days)
Note Ranges assume ~normal distribution & historical patterns repeat. Use with caution.

Moderate gain for Aclaris Therapeutics Incon Thursday .

Aclaris Therapeutics Inc (ACRS) stock price delivered a strong performance on Thursday after the stock rose $0.0800 (1.81%) from the previous session on extraordinarily high volume. The stock moved in line with the rising NASDAQ that gained 1.91%. Yesterday's trading volume was 4.32M shares, worth about $19.45M. This represents 3.14M shares more than the day before. Volume was above the 10-day average of 1.16M shares.

Aclaris Therapeutics Inc signals

There is no conclusive signals given from RSI. The price is above both the short- and long-term averages, and the short-term average is above the long-term average, confirming an established up-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (3.3%), medium- (3.3%), and long-term (3.3%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.

Aclaris Therapeutics Inc Support & Resistance Levels

The stock is approaching the closest resistance level at $4.53. approximately $0.0300 (0.67%) away. Pushing up towards resistance. Breaking above this level could signal further upside where next resistance level will be found at $4.55. On a fall back there will be support at $4.43 The dis das resistance s14.43 -

Aclaris Therapeutics Inc Evaluation

  • Court score: -0.41
  • Moyen score: 0.74
  • Long score: 1.25